Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-ranging trial of litoxetine in women with mixed urinary incontinence
2016-004307-30Phase 2Completed
- Sponsor
- IXALTIS
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of litoxetine in Mixed incontinence (MUI) (4 arms), sponsored by IXALTIS. Started Mar 2017; status: completed.
02
Drugs
litoxetine
03
Conditions
Mixed incontinence (MUI)
Beyond the preview
Go deeper on 2016-004307-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004307-30.